High-impact clinical trial results to be presented at ASN Kidney Week 2023

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2023 November 1–November 5.

Related Keywords

Tokyo ,Japan ,Groningen ,Netherlands ,France ,Monaco ,Canada ,Brad Rovin ,Michelle Rheault ,Danielle Ellis ,Hiddo Lambers Heerspink ,Patrick Rossignol ,Tadao Akizawa ,Amit Garg ,Dan Brennan ,Katheriner Tuttle ,University Of Lorraine ,Showa University School Of Medicine ,University Of Washington ,Drug Administration ,University Of Minnesota Medical School ,Ohio State University ,London Health Sciences Centre Research Institute ,University Medical Center Groningen ,Ohio State ,Minnesota Medical ,Focal Segmental Glomerulosclerosis ,Showa University School ,Placebo Controlled Phase ,Bardoxolone Methyl ,Diabetic Kidney Disease ,Aldosterone Synthase Inhibition ,Without Background Sodium Glucose Cotransporter ,Dapagliflozin Alone ,Interventional Survival Trial ,Princess Grace Hospital ,Antagonist Chronic ,Primary Results ,Western University ,Multi Component Intervention ,Improve Patient Access ,Kidney Transplantation ,Living Kidney ,Medeor Therapeutics ,Chief Medical Officer Dan Brennan ,Operational Immune Tolerance Achieved ,Living Related ,Matched Kidney Transplant ,Kidney ,Albuminuria ,Aldosterone ,Ngiotensin ,Flood ,Blood Pressure ,Children ,Hronic ,Clinical Trial ,Dialysis ,Efficacy ,Endothelin ,Wood ,Glomerulosclerosis ,Lomerulus ,Glucose ,Heart ,Heart Failure ,Iga Nephropathy ,Mmunoglobulin ,Immunosuppression ,Kidney Disease ,Kidney Failure ,Kidney Transplant ,Nephrology ,Ephropathy ,Placebo ,Potassium ,Protein ,Proteinuria ,Eceptor ,Research ,Transplant ,